BLA
IMPV

Balter Liquid Alternatives’s Imperva, Inc. IMPV Stock Holding History

Balter Liquid Alternatives’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,739
Closed -$418K – 176
2017
Q2 		$418K Buy
+8,739
New +$408K 0.48% 62

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Balter Liquid Alternatives's IMPV Position: Q3 2017 in Review

Balter Liquid Alternatives sold out of Imperva, Inc. (IMPV) in Q3 2017, closing a stake of 8,739 shares — an estimated $418K sold.

Balter Liquid Alternatives first reported a position in IMPV in Q2 2017 and held it in 1 quarter. The position peaked at $418K in Q2 2017. 171 funds tracked by Wall St. Rank hold IMPV as of Q3 2017.

  • Balter Liquid Alternatives reported no remaining Imperva, Inc. position as of Q3 2017 after selling out during the quarter.
  • Balter Liquid Alternatives sold 8,739 Imperva, Inc. shares in Q3 2017, an estimated $418K.
  • Balter Liquid Alternatives first reported a position in Imperva, Inc. in Q2 2017 and held it in 1 quarter.
  • Balter Liquid Alternatives's Imperva, Inc. position peaked at $418K in Q2 2017.
  • 171 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2017.

Based on Balter Liquid Alternatives's 13F filing for Q3 2017, filed 16 Oct 2017.